GAN-1

GAN | 2000

What Is GAN-1?

GAN-1 is a type of CMT caused by autosomal recessive mutations in the GAN gene. This gene provides instructions for making gigaxonin, a protein that regulates the organization and turnover of the neurofilament network that gives nerve axons their structure. Mutations in the GAN gene disrupt this function, leading to impaired nerve signal transmission.

GAN-1 is autosomal recessive, meaning that both copies of the gene must have a mutation to cause this subtype.

Clinical Features

Symptoms of GAN-1 typically begin in early childhood and affect both the peripheral and central nervous systems. The disease is defined by the formation of abnormally enlarged nerve axons swollen with disorganized neurofilaments. Nerve conduction studies reflect a severe axonal process.

GAN-1 symptoms may include:

  • Tightly curled, kinky hair that differs from the parents
  • Progressive weakness and muscle atrophy of the limbs
  • Reduced sensation in the hands and feet
  • Reduced or absent reflexes
  • Difficulty walking and coordination problems
  • Central nervous system involvement, which may include seizures and cognitive impairment
  • Foot drop
  • Additional symptoms not listed here

Disease Course

GAN-1 is a severe, progressive disease of childhood onset. Both the peripheral and central nervous systems are affected, and most individuals lose the ability to walk during childhood or adolescence. The disease course is serious, with progression continuing over time.

Clinical Basics

Subtype
GAN-1

Classification
GAN

Neuropathy Type
Axonal

Inheritance Pattern
autosomal recessive

Genetic Context

HGNC-Approved Gene Symbol
GAN

Gene Full Name
Gigaxonin

HGNC Gene Alias(es)
GAN1

Chromosome
16q23.2

Zygosity of Responsible Variant
Homozygous or Compound Heterozygous

Variant Mechanism
Loss of Function (LoF)

ClinVar Pathogenic Variants

View GAN-1 ClinVar Variants

GAN-1 OMIM Entry

GAN-1 OMIM

GAN OMIM Entry

GAN OMIM

More Info

GAN-1 Research Opportunity

CMT Natural History Study

Original Discovery Publication

Publication Title

The Gene Encoding Gigaxonin, a New Member of the Cytoskeletal BTB/Kelch Repeat Family, is Mutated in Giant Axonal Neuropathy

Authors

Bomont, P., Cavalier, L., Blondeau, F., Ben Hamida, C., Belal, S., Tazir, M., Demir, E., Topaloglu, H., Korinthenberg, R., Tüysüz, B., Landrieu, P., Hentati, F., & Koenig, M.

Publication Date
November 1, 2000

Updated: July 18, 2026 | By: K. Raymond

The Dorsal Root

More From The Dorsal Root


Close-up of a doctor’s hand holding a prescription pad while a patient’s wrist is wrapped with metal chains.


When Medicine Lost Its Compass

Evidence failed not because it was wrong, but because it was weaponized. I lived the downstream effects of that failure for more than a decade. This is what happens when medicine forgets that data always ends in a human being.


Illustrated graphic showing large ‘404’ numerals with people interacting with data screens and servers, alongside text reading ‘CMT Genetic Testing Error 404: Gene Not Found’ and ‘Examining Why Less Than Half of All Who Have Charcot-Marie-Tooth Disease Are Not Able to Obtain Genetic Confirmation of Their Disease.


Error 404: Gene Not Found

CMT genetic testing often fails to identify the cause of the disease, even when comprehensive panels are used. Here, we discuss why this happens, what genetic tests can and cannot do, and why a negative result still matters.


Illustrated cover graphic showing a split landform with branching directional arrows, two people with question marks above their heads, and the title ‘SORD Deficiency: Decoding This Newly Discovered and Confusing CMT Subtype.


CMT-SORD: What Is This Unique CMT Subtype?

CMT-SORD is a newly discovered CMT subtype driven by toxic sorbitol accumulation. This article explains how "SORD" works, why this subtype is different, and how it led to the fastest-moving therapeutic program in CMT history.